Results 181 to 190 of about 64,330 (231)
Early oxygenator failure during cardiopulmonary bypass with preserved neurological outcome: a case report. [PDF]
Khan M, Naved SA, Rajput MZ, Shah MUA.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Thromboelastography and Cardiopulmonary Bypass
Seminars in Thrombosis and Hemostasis, 2012The TEG tracks postoperative hemorrhage after CPB and is useful in guiding therapy. Its ability to characterize the overall interaction of all procoagulant participants in a final outcome (clot strength) is unique. Much work in the future is needed to establish the particular applications for TEG monitoring in CPB ...
openaire +2 more sources
Neonatal Cardiopulmonary Bypass
Seminars in Thoracic and Cardiovascular Surgery: Pediatric Cardiac Surgery Annual, 2013Cardiac surgery with cardiopulmonary bypass is routinely used in neonates who require early repair of congenital heart diseases. However, the bypass temperature and use of deep hypothermic circulatory arrest, the composition of the priming and the acceptable degree of hemodilution, the prophylactic use of antifibrinolytic agents and steroids, the ...
Philippe, Pouard, Mirela, Bojan
openaire +2 more sources
Miniaturization in cardiopulmonary bypass
Perfusion, 2003Cardiopulmonary bypass (CPB) remains the key technology for more complex cardiac operations. The perfusion equipment used nowadays has seen tremendous progress since its introduction into clinical practice 50 years ago. However, overall, CPB is still far from perfect.
von Segesser LK +5 more
openaire +3 more sources
Biomaterials in cardiopulmonary bypass
Perfusion, 1994The improved utilization of biomaterials in cardiopulmonary bypass is dependent on polymer science and technology, procedures for blood compatibility assessment, optimization of biomaterial/antithrombotic agent combinations and the interpretation of clinical data.
James M. Courtney +4 more
openaire +2 more sources
The platelet in cardiopulmonary bypass
The Annals of Thoracic Surgery, 1998Platelets are the smallest of the blood cells and are known to be activated during cardiopulmonary bypass. They play a role in many associated complications. Both quantitative and qualitative platelet defects have been demonstrated, resulting in microvascular hemorrhage and thromboembolism.
A, Weerasinghe, K M, Taylor
openaire +2 more sources

